Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
Evan A. Stein(Oncotherapeutics (United States)), Mary P. McGowan(Heart Foundation), Daniel Gaudet(Brigham and Women's Hospital), Cara East(Université du Québec à Chicoutimi), Diane L. Tribble(Lawrence Berkeley National Laboratory), Claude Gagné(Hôpital Notre-Dame), Wai Chin(Université du Québec à Chicoutimi), Joanne M. Donovan(Université du Québec à Chicoutimi), Robert Dufour(Myovant Sciences (United States))
Cited by 299
Related Papers
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
|Nature Genetics|2000|1.8k
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
|New England Journal of Medicine|2015|1.5k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Hypertriglyceridemic Waist
|Circulation|2000|934